SCHEMBL7570433

SCHEMBL7570433

COc1ccccc1-n1cc(C#N)c(C(F)(F)F)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.42
PGR P06401 1/20 0.42
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KCNN4 O15554 1/20 0.39
DRD2 P14416 3/20 0.38
ALDH1A1 P00352 1/20 0.38
HTR7 P34969 2/20 0.38
ALOX15 P16050 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR1A P08908 1/20 0.37
HTR2A P28223 1/20 0.37
MGLL Q99685 1/20 0.37
IMPDH2 P12268 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407661 0.71 DGAT1 (0.47) MAPTLMNAMAPK1HTTALDH1A1
SCHEMBL2045755 0.69 MTOR (0.44) MAPTTSHRDRD2ALDH1A1HTR1A
SCHEMBL1528319 0.69 MAPT (0.52) MAPTNPC1RAB9ADRD2ALDH1A1
SCHEMBL31149031 0.69 MTOR (0.44) MAPTTSHRDRD2ALDH1A1HTR1A
SCHEMBL6173838 0.69 GRIA2 (0.40) MAPTLMNAHTTNPC1ALDH1A1
SCHEMBL5801912 0.68 MTOR (0.43) ARMAPTLMNANPC1KCNN4
SCHEMBL29524027 0.68 TSHR (0.41) ARMAPTLMNATSHRHTT
SCHEMBL1195395 0.67 LMNA (0.37) ARMAPTLMNAHTTALDH1A1
SCHEMBL6170354 0.66 MEN1 (0.43) MAPTLMNAHTTNPC1RAB9A
SCHEMBL7241605 0.65 MEN1 (0.45) MAPTTSHRMAPK1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991625-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-12 EP disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 WO disclosed